JPH0118071B2 - - Google Patents

Info

Publication number
JPH0118071B2
JPH0118071B2 JP54162896A JP16289679A JPH0118071B2 JP H0118071 B2 JPH0118071 B2 JP H0118071B2 JP 54162896 A JP54162896 A JP 54162896A JP 16289679 A JP16289679 A JP 16289679A JP H0118071 B2 JPH0118071 B2 JP H0118071B2
Authority
JP
Japan
Prior art keywords
acid
fluoro
methylphenyl
imidazolidine
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54162896A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5583754A (en
Inventor
Sutaare Herumutsuto
Kotsupe Heruberuto
Kumaa Berunaa
Barando Arekusandaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of JPS5583754A publication Critical patent/JPS5583754A/ja
Publication of JPH0118071B2 publication Critical patent/JPH0118071B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Luminescent Compositions (AREA)
JP16289679A 1978-12-18 1979-12-17 Imidazolidine derivative Granted JPS5583754A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782854659 DE2854659A1 (de) 1978-12-18 1978-12-18 Neue 3,4-disubstituierte 2-phenylimino-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
JPS5583754A JPS5583754A (en) 1980-06-24
JPH0118071B2 true JPH0118071B2 (OSRAM) 1989-04-03

Family

ID=6057553

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16289679A Granted JPS5583754A (en) 1978-12-18 1979-12-17 Imidazolidine derivative

Country Status (18)

Country Link
EP (1) EP0012822B1 (OSRAM)
JP (1) JPS5583754A (OSRAM)
AT (1) ATE1903T1 (OSRAM)
AU (1) AU526539B2 (OSRAM)
CA (1) CA1112648A (OSRAM)
DE (2) DE2854659A1 (OSRAM)
DK (1) DK146821C (OSRAM)
ES (3) ES486971A0 (OSRAM)
FI (1) FI68814C (OSRAM)
GR (1) GR73913B (OSRAM)
IE (1) IE49239B1 (OSRAM)
IL (1) IL58971A (OSRAM)
NO (1) NO148555C (OSRAM)
NZ (1) NZ192426A (OSRAM)
PH (1) PH22130A (OSRAM)
PT (1) PT70592A (OSRAM)
YU (1) YU41901B (OSRAM)
ZA (1) ZA796832B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2933930A1 (de) * 1979-08-22 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim 2-(2-chlor-4-cyclopropyl-phenylimino)-imidazolidin, dessen saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben.
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
EP0775134A4 (en) * 1994-08-04 1997-08-13 Synaptic Pharma Corp NEW BENZIMIDAZOLE DERIVATIVES
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
JP2001506605A (ja) * 1996-11-25 2001-05-22 ザ プロクター アンド ギャンブル カンパニー ２―アミノ―２―イミダゾリン、グアニジン、および２―アミノ―３，４，５，６―テトラヒドロピリミジン誘導体の製造法
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
US6066740A (en) * 1997-11-25 2000-05-23 The Procter & Gamble Company Process for making 2-amino-2-imidazoline, guanidine and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives
CN111303038A (zh) * 2020-03-18 2020-06-19 滨州德润化工有限责任公司 一种油田水处理用缓蚀剂两性咪唑啉制作工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123037C (OSRAM) * 1963-10-04
BE687656A (OSRAM) * 1965-10-01 1967-03-30
DE1545628A1 (de) * 1965-10-01 1970-06-25 Boehringer Sohn Ingelheim Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-(2-Halogenanilino)-1,3-diazacyclopentens-(2)
AT278775B (de) * 1967-01-19 1970-02-10 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Δ<2>-Imidazolinderivaten und ihren Salzen
AT330769B (de) * 1974-04-05 1976-07-26 Chemie Linz Ag Verfahren zur herstellung von 2-arylamino- 2-imidazolin-derivaten und ihren salzen
DE2806775A1 (de) * 1978-02-17 1979-08-30 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben

Also Published As

Publication number Publication date
EP0012822B1 (de) 1982-12-01
ES486970A0 (es) 1980-12-16
ZA796832B (en) 1981-08-26
GR73913B (OSRAM) 1984-05-22
IE49239B1 (en) 1985-09-04
NO148555C (no) 1983-11-23
NO794114L (no) 1980-06-19
JPS5583754A (en) 1980-06-24
PH22130A (en) 1988-06-01
IE792447L (en) 1980-06-18
ES8103054A1 (es) 1981-02-16
EP0012822A1 (de) 1980-07-09
PT70592A (de) 1980-01-01
DK146821B (da) 1984-01-16
DE2854659A1 (de) 1980-07-10
NO148555B (no) 1983-07-25
DK537179A (da) 1980-06-19
NZ192426A (en) 1984-07-06
AU5389379A (en) 1980-06-26
FI68814C (fi) 1985-11-11
FI793948A7 (fi) 1980-06-19
ES486967A0 (es) 1981-02-16
AU526539B2 (en) 1983-01-20
DK146821C (da) 1984-06-25
FI68814B (fi) 1985-07-31
ATE1903T1 (de) 1982-12-15
IL58971A (en) 1984-03-30
ES8102100A1 (es) 1980-12-16
YU41901B (en) 1988-02-29
ES8100272A1 (es) 1980-11-01
DE2964166D1 (en) 1983-01-05
ES486971A0 (es) 1980-11-01
YU308979A (en) 1983-04-30
IL58971A0 (en) 1980-03-31
CA1112648A (en) 1981-11-17

Similar Documents

Publication Publication Date Title
US4072759A (en) Novel benzylalcohol derivatives as antidiabetics and cardiotonics
EP0377488A1 (en) Novel beta-adrenergic agonists
JPS6340167B2 (OSRAM)
JPH0428269B2 (OSRAM)
JPS587629B2 (ja) プロパノ−ルアミンユウドウタイ
KR0150649B1 (ko) 술폰아닐리드 유도체 및 의약
JPH0118071B2 (OSRAM)
JPS6340784B2 (OSRAM)
SK216092A3 (en) Using of xantine derivatives for treating of secondary lesions of neurous cells and functional defects after injuring of cranium and cerebrum
JPS6117574A (ja) カルシウム拮抗活性のある１‐〔ビス‐（４‐ルオロフエニル）‐メチル〕‐４‐（３‐フエニル‐２‐プロペニル）‐ヘキサヒドロ‐１ｈ‐１，４‐ジアゼピンとその製法及びそれを含有する医薬組成物
JP7050336B2 (ja) 重水素化化合物及びその医薬的用途
US4720580A (en) N-(aminoalkylene)benzenesulfonamides
HUT70174A (en) New 3-phenyl-sulphonyl-3,7-diazabicyclo [3.3.1] nonane compounds and pharmaceutical compounds containing the same
JPS61165324A (ja) 心臓脈管系疾患治療剤
JPH0127073B2 (OSRAM)
EP0125046B1 (en) Process for preparing pyrimidinetrione derivatives
JPH0788369B2 (ja) ブチロラクトン誘導体、その製造方法およびその用途
US4128555A (en) 3-Phenoxypyridine monosulfate and a method for its production
HU196069B (en) Process for production of 8-/dihydropiridil-carbamoiloxi-methil/-ergolines and medical compounds containing these compositions
US2758997A (en) 7-chloro-4-(4-di-n-butylaminobutylamino)-3-methylquinoline and salts thereof
JPS58148883A (ja) ピリドベンゾジアゼピノン化合物
JP2598309B2 (ja) ３−環状アミノプロパノール誘導体及びその塩
JP2989059B2 (ja) 置換アニリド
JP3112754B2 (ja) シクロアルケノン化合物及び該化合物を有効成分とする脳機能改善薬
JPH0641102A (ja) 新規チオセミカルバゾン酸エステル